These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. CONTRASTING ABNORMALITIES IN THE THYMUS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS: A QUANTITATIVE HISTOLOGICAL STUDY. GOLDSTEIN G; MACKAY IR Aust J Exp Biol Med Sci; 1965 Jul; 43():381-90. PubMed ID: 14343498 [No Abstract] [Full Text] [Related]
47. Myasthenia as an autoimmune disease: clinical aspects. Wolf SM; Rowland LP; Schotland DL; McKinney AS; Hoefer PF; Aranow H Ann N Y Acad Sci; 1966 Jan; 135(1):517-35. PubMed ID: 5329160 [No Abstract] [Full Text] [Related]
48. Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection. Caponnetto C; Rossi E; Primavera A Eur Neurol; 2001; 46(1):53-4. PubMed ID: 11455187 [No Abstract] [Full Text] [Related]
49. [Immune-pathological concomitant diseases and phenomena of lupus erythematosus]. Meyer zum Büschenfelde ; Gamp A; Schilling F Klin Wochenschr; 1965 Aug; 43(16):892-8. PubMed ID: 5867890 [No Abstract] [Full Text] [Related]
50. Systemic lupus erythematosus associated with myasthenia gravis, pemphigus foliaceus and chronic thyroiditis after thymectomy. Sawamura S; Kajihara I; Makino K; Makino T; Fukushima S; Jinnin M; Oyama B; Hashimoto T; Ihn H Australas J Dermatol; 2017 Aug; 58(3):e120-e122. PubMed ID: 27270472 [TBL] [Abstract][Full Text] [Related]
51. Multiple dermatofibromas in patients with autoimmune disease. A case report. Harvey CK; Park E J Am Podiatr Med Assoc; 1994 Oct; 84(10):523-5. PubMed ID: 7965687 [No Abstract] [Full Text] [Related]
52. The course of myasthenia gravis with systemic lupus erythematosus. Bekircan-Kurt CE; Tuncer Kurne A; Erdem-Ozdamar S; Kalyoncu U; Karabudak R; Tan E Eur Neurol; 2014; 72(5-6):326-9. PubMed ID: 25323839 [TBL] [Abstract][Full Text] [Related]
53. Systemic lupus erythematosus after thymectomy in a patient with myasthenia gravis. Sant SM Ir Med J; 1997; 90(3):116, 118. PubMed ID: 9183101 [No Abstract] [Full Text] [Related]
54. Autoimmune optic neuritis: a potentially treatable form of visual loss. Fleet WS; Watson RT Ann Ophthalmol; 1986 Apr; 18(4):144-6. PubMed ID: 3592470 [TBL] [Abstract][Full Text] [Related]
55. Pemphigus foliaceus, myasthenia gravis, and thymoma in a patient with serological evidence of SLE. Cooper A; Wells JV Aust N Z J Med; 1981 Jun; 11(3):277-80. PubMed ID: 6945842 [No Abstract] [Full Text] [Related]
56. [A case of systemic lupus erythematosus following thymectomy for myasthenia gravis]. Ohnishi K; Sagawa A; Fujisaku A; Mukai M; Shimizu M; Oki I; Yanagihara T; Maruo Y; Tashiro K; Nakagawa S Ryumachi; 1985 Nov; 25(5):355-61. PubMed ID: 3832478 [No Abstract] [Full Text] [Related]
57. Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient. MacKechnie HL; Squires AH; Platts M; Pruzanski W Can Med Assoc J; 1973 Oct; 109(8):733-8. PubMed ID: 4126868 [TBL] [Abstract][Full Text] [Related]
58. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Calabrese LH; Bach JF; Currie T; Vidt D; Clough J; Krakauer RS Arch Intern Med; 1981 Feb; 141(2):253-5. PubMed ID: 6450575 [TBL] [Abstract][Full Text] [Related]